Cargando…
Antibody-Mediated “Universal” Osteoclast Targeting Platform using Calcitonin as a Model Drug
PURPOSE: To generate and characterize a specific monoclonal antibody (mAb) against recombinant human RANK receptor and to develop an antiresorptive strategy using this mAb as an osteoclast-targeting platform that selectively targets osteoclast cells whilst delivering an attached (i.e. chemically con...
Autores principales: | Newa, Madhuri, Bhandari, Krishna Hari, Tang, Lili, Kalvapalle, Rohit, Suresh, Mavanur, Doschak, Michael R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073043/ https://www.ncbi.nlm.nih.gov/pubmed/21301934 http://dx.doi.org/10.1007/s11095-011-0376-y |
Ejemplares similares
-
THE EFFECTS OF PARATHYROID HORMONE, COLCHICINE, AND CALCITONIN ON THE ULTRASTRUCTURE AND THE ACTIVITY OF OSTEOCLASTS IN ORGAN CULTURE
por: Holtrop, Marijke E., et al.
Publicado: (1974) -
Calcitonin controls bone formation by
inhibiting the release of sphingosine
1-phosphate from osteoclasts
por: Keller, Johannes, et al.
Publicado: (2014) -
Calcitonin Inhibits SDCP-Induced Osteoclast Apoptosis and Increases Its Efficacy in a Rat Model of Osteoporosis
por: Kuo, Yi-Jie, et al.
Publicado: (2012) -
Bispecific Antibodies for Diagnostic Applications
por: Parashar, Archana, et al.
Publicado: (2011) -
Sequential affinity purification of peroxidase tagged bispecific anti-SARS-CoV antibodies on phenylboronic acid agarose
por: Bhatnagar, Pravin K., et al.
Publicado: (2008)